Further cash for GSK shareholders as Aspen fronts £164 million for RoW OTC products

 
• By Eleanor Malone
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category